https://www.biosciencedesk.com/news/atomic-vs-neoprism-crc-dmmr-colon-cancer-treatment-sequencing BioScienceDesk en 2026-10-11T09:15:44.037Z ATOMIC vs. NEOPRISM-CRC: Is the Next Big Shift in dMMR Colon Cancer Happening Before or After Surgery? ATOMIC Trial, NEOPRISM-CRC, Atezolizumab, Tecentriq, Tecentriq Hybreza, Pembrolizumab https://www.biosciencedesk.com/news/halozyme-blocks-merck-subcutaneous-keytruda-launch-europe-patent-injunction BioScienceDesk en 2026-10-09T10:30:00.000Z Halozyme Wins Dutch Injunction Against Merck’s Subcutaneous Keytruda in Eight European Countries Keytruda SC, Keytruda Qlex, Merck, Halozyme Therapeutics, Alteogen, Berahyaluronidase Alfa